OpenAlex
PricingAboutJobs
Log inGet started
Author

Jeannette Salsetta

Observed name: J. Salsetta
Institution: Fondazione IRCCS Istituto Nazionale dei Tumori
Observed institution: Fondazione IRCCS Istituto Nazionale dei Tumori
ORCID: 0009-0006-4790-5781
Observed ORCID: 0009-0006-4790-5781
OpenAlex ID: A5113106644
Reprogramming the melanoma and immunosuppressive myeloid cells with esomeprazole-loaded PLGA nanoparticles
2024 · Nicola Cerioli, Wissem Bououdina, et al. · iScience · 7
Pazopanib-associated remodeling of platelet-immune cell crosstalk and immune suppressive platelet-derived extracellular vesicles in metastatic RCC
2026 · Gianpiero Lupoli, Stefano Bergamini, et al. · Frontiers in Immunology · 3
PDF
Liquid biopsy as promising source of plasma extracellular vesicle biomarkers of response to cabozantinib (CABO) plus durvalumab (DURVA) in patients with advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) after platinum chemotherapy: The phase 2 ARCADIA trial.
2024 · Alessandro Mereu, Jeannette Salsetta, et al. · Journal of Clinical Oncology
PDF
26P Liquid biopsy as promising source of plasma extracellular vesicle biomarkers of response to cabozantinib (CABO) plus durvalumab (DURVA) in advanced urothelial carcinoma (UC) or non-UC variant histologies (VH) patients (the phase II ARCADIA trial)
2023 · V. Huber, A. Mereu, et al. · Immuno-Oncology Technology
PDF
Works count: 4
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security